DCF Advisers, LLC CRVS — CORVUS PHARMACEUTICALS INC

Ownership history in DCF Advisers, LLC  ·  6 quarters on record

AI Ownership Summary

DCF Advisers, LLC reported CORVUS PHARMACEUTICALS INC (CRVS) in 6 quarterly 13F filings from 2025 Q1 through 2026 Q1. Peak portfolio weight reached 2.49% in 2026 Q1. The latest visible filing shows CRVS at 2.49% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CRVS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was DCF Advisers, LLC's position in CORVUS PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CRVS was reported at 2.49% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
2.49% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CRVS stock page DCF Advisers, LLC fund profile DCF Advisers, LLC full holdings
How DCF Advisers, LLC held CRVS — position size vs. price
% of Fund (quarterly)    CRVS price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 6 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 637,500 -91,500 -12.6% 2.49% $9.3M 2026-05-11 $15.81
2025 Q4 ADDED — — — 729,000 +726,500 +29060.0% 1.51% $5.6M 2026-02-11 $19.74
2025 Q2 REDUCED 99.7% +82.0% ❌ 2,500 -755,000 -99.7% 0.00% $10K 2025-08-12 $4.50
2025 Q2 ADDED — — — 757,500 +752,500 +15050.0% 1.40% $3.0M 2025-08-12 $4.50
2025 Q1 REDUCED 98.8% +25.8% ❌ 5,000 -395,000 -98.8% 0.01% $16K 2025-05-09 $4.43
2025 Q1 INITIATED — — — 400,000 — — 0.61% $1.3M 2025-05-09 $4.43

🏢 Other funds also holding CRVS

As of 2026 Q1 — sorted by position size

ADAMS STREET PARTNERS LLC 3Y 7Y 18.41% Foresite Capital Management VI LLC 5.82% Vivo Capital, LLC 3Y 7Y 3.43% Catalio Capital Management, LP 2.73% Blue Owl Capital Holdings LP 3Y 2.14% Boxer Capital Management, LLC 2.11% ORBIMED ADVISORS LLC 3Y 7Y 2.08% Commodore Capital LP 3Y 1.91% MPM BioImpact LLC 3Y 1.89% BRAIDWELL LP 3Y 0.86%

FAQ About DCF Advisers, LLC and CRVS

These are the practical questions this page is built to answer before you even open the full history table.

How long has DCF Advisers, LLC reported owning CRVS?

DCF Advisers, LLC reported CRVS across 6 quarterly 13F filings, from 2025 Q1 through 2026 Q1.

What was the largest reported CRVS position in DCF Advisers, LLC's portfolio?

The largest reported portfolio weight for CRVS was 2.49% in 2026 Q1.

What is the latest reported CRVS position on this page?

The most recent filing on this page is 2026 Q1, when DCF Advisers, LLC reported 637,500 shares, equal to 2.49% of portfolio, with an estimated market value of $9.3M.

What does the chart on this CRVS ownership page compare?

The chart compares DCF Advisers, LLC's quarterly CRVS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did DCF Advisers, LLC time their CRVS position?

Based on 13F filing dates vs. subsequent CRVS price moves, DCF Advisers, LLC correctly timed 0 out of 5 reported position changes (0%). The annualised alpha on CRVS relative to SPY over the holding period was +243.5%.

← Back to DCF Advisers, LLC Holdings